Fonte: Frontiers in Immunology. Unidade: ICB
Assuntos: IMUNOLOGIA, CÉLULAS DENDRÍTICAS, CELULAS CULTIVADAS DE TUMOR, IMUNOTERAPIA, NEOPLASIAS
ABNT
ROMAGNOLI, Graziela Gorete et al. Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets. Frontiers in Immunology, v. 5, p. 1-5, 2015Tradução . . Disponível em: https://doi.org/10.3389/fimmu.2014.00692. Acesso em: 24 jul. 2024.APA
Romagnoli, G. G., Zelante, B. B., Toniolo, P. A., Migliori, I. K., & Barbuto, J. A. M. (2015). Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets. Frontiers in Immunology, 5, 1-5. doi:10.3389/fimmu.2014.00692NLM
Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK, Barbuto JAM. Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets [Internet]. Frontiers in Immunology. 2015 ; 5 1-5.[citado 2024 jul. 24 ] Available from: https://doi.org/10.3389/fimmu.2014.00692Vancouver
Romagnoli GG, Zelante BB, Toniolo PA, Migliori IK, Barbuto JAM. Dendritic cell-derived exosomes may be a tool for cancer immunotherapy by converting tumor cells into immunogenic targets [Internet]. Frontiers in Immunology. 2015 ; 5 1-5.[citado 2024 jul. 24 ] Available from: https://doi.org/10.3389/fimmu.2014.00692